In this episode, NCI SBIR Director Michael Weingarten invites Matthew Gevaert, Ph.D., cofounder of Kiyatec to discuss the company's journey. The NCI SBIR-funded cancer therapeutics company developed an innovative 3D cell culture platform that uses patients' live tissue to assess and predict how tumor cells respond to therapies and inform more personalized treatment paths.

SBIR DEVELOPMENT CENTER
SBIR Innovation Lab Podcast: https://sbir.cancer.gov/about/innovation-lab-podcast
SBIR Development Center: https://sbir.cancer.gov/

LEARN MORE FROM THE NATIONAL CANCER INSTITUTE
Online: https://www.cancer.gov
By Phone: 1-800-4-CANCER (1-800-422-6237)

U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute